The role of the pancreatic acinar cell in acute pancreatitis:
Pancreatic necrosis, systemic inflammatory response syndrome, multiple organ failure and sepsis are characteristic of severe acute pancreatitis, which results in death of one in four patients and is without specific drug therapy (59, 62) . As the pancreatic acinar cell is an initial site of injury (41, 59) , commonly initiated by bile or ethanol excess, investigation of its behaviour in response to toxins that induce acute pancreatitis may determine critical mechanisms and importantly identify new drug targets. In view of the critical role of calcium signaling in normal stimulus-secretion and stimulus-metabolism coupling, and the long known toxicity of raised intracellular calcium, we proposed the hypothesis that prolonged elevations of cytosolic calcium is the key trigger of acute pancreatitis (83) . Since that proposal over 20 years ago, increasing evidence has confirmed that sustained elevation of the cytosolic calcium concentration ([Ca 2+ ] C ) is a critical trigger for pancreatic acinar cell injury and necrosis that depends on store-operated calcium entry (SOCE) (12, 24, 36, 39, 63, 84) .
The critical role of calcium entry in acinar cell injury:
Intracellular Ca 2+ signals control normal secretion from pancreatic acinar cells but can become a critical trigger in pathogenesis. Physiological concentrations of acetylcholine (ACh) and cholecystokinin (CCK) generate repetitive elevations in [Ca 2+ ] C within the cellular apical pole that elicit stimulus-metabolism coupling to generate adenosine triphosphate (ATP) from mitochondria and stimulus-secretion coupling to initiate exocytosis (61) . Intermittently, global extension of short-lived signals throughout the cell are necessary for nuclear signalling contributing to transcription and translation (61) . Elevations of [Ca 2+ ] C are buffered in mitochondria, notably those surrounding the apical pole, with subsequent reuptake into the endoplasmic reticulum (ER) by sarcoER Ca 2+ ATPase (SERCA) pumps and extrusion by plasma membrane calcium pump (PMCA) (Figure 1 ). In contrast, toxins such as bile acids (81) , oxidative (70) and non-oxidative metabolites (12, 34) of ethanol and CCK hyperstimulation (10, 53) signaling and enzyme secretion (21) . Stimuli such as CCK (7) the bile acid taurolithocholic acid 3-sulphate (TLCS) (23, 79) , alcohol (25) and fatty acid ethyl esters (FAEEs) (12, 26) (26, 53) .
Since the discovery of the calcium entry channel ORAI1, ORAI1 has been shown to be the principal SOCE channel in the pancreatic acinar cell (45) , opening of which is coordinated by stromal interaction molecules (STIM1 and STIM2), following decreases in ER calcium store concentrations (16, 24, 45, 50) . (38) . These experiments supported a role for SOCE in acute pancreatitis, but in a single, mild model with few parameters of response.
As indicated we have defined the concentrationdependent inhibitory effects of GSK-7975A and CM_128 on SOCE and necrosis in murine and human pancreatic acinar cells induced by TLCS (60, 79) or CCK-8 (38, 63) . The effects of CM_128 on ORAI1 were confirmed by examination of its effect on Ca 2+ release-activated Ca 2+ currents (I CRAC ) (16, 24, 50) , in ORAI1/STIM1-transfected HEK 293 cells (16) . GSK-7975A was given at selected doses in vivo after induction of acute pancreatitis with TLCS (TLCS-AP) (40) , seven injections of cerulein (CER-AP) (43) or ethanol and palmitoleic acid (FAEE-AP) (34) . Since GSK-7975A markedly reduced all parameters of pathobiologic response in a dose-dependent manner, a high dose of GSK-7975A and separately CM_128 was begun at two different time points after disease induction to determine the effect of early versus late drug administration. Drug administration begun one hour after disease induction was highly effective in reducing parameters of the pathobiologic response (84), significantly more so than when begun six hours after disease induction, in all models. These data provide thorough preclinical validation for ORAI channel inhibition as a potential early treatment for acute pancreatitis.
We found GSK-7975A and the new molecular entity CM_128 to inhibit toxin-induced SOCE into murine and human pancreatic acinar cells in a concentration-dependent manner, exceeding >90% block of relative control values in some protocols (84) . We also found both GSK-7975A and CM_128 to significantly reduce necrotic cell death pathway activation in murine and human pancreatic acinar cells exposed to TLCS, which induces acute pancreatitis in vivo (40, 43) . While effects of GSK-7975A have been described on thapsigargin-and FAEE-induced murine pancreatic acinar SOCE (24), our studies found GSK-7975A to have a similarly critical effect on TLCS-and CCK-induced murine pancreatic acinar SOCE, as well as thapsigargin-induced human pancreatic acinar SOCE and TLCSinduced human pancreatic acinar necrotic cell death pathway activation (84) . CM_128 showed higher potency (IC 50 ~0.1 µM from ORAI1/STIM1-transfected HEK 293 cell patch clamp data), and unlike GSK-7975A, no loss of efficacy at high doses. Comprehensive in vivo evaluation using three diverse, clinically representative models of acute pancreatitis (84) with prior pharmacokinetic assessment demonstrated the validity of SOCE inhibition as a therapeutic approach. Thus administration of either compound within one hour following disease induction was markedly effective across a representative range of local and systemic biochemical, immunological and histological disease responses. These data provide robust confirmation of the hypothesis that cytosolic Ca 2+ overload is a critical trigger of acute pancreatitis (83) .
Further confirmation of the role of cytosolic Ca 2+ overload in acute pancreatitis has come from our 4 work with xanthines (35 half-life of caffeine in mice of ~60 min (4), the combined peak concentrations of di-and trimethylxanthines with 25 mg/kg caffeine regimen (7 injections) were >2 mM, and serum caffeine was >400 μM 6 h after last caffeine injection. Following similar protocols of 25 mg/kg theophylline or paraxanthine, concentrations were far below the effective range on IP 3 Rs but within the effective range on PDE (approaching 100 µM 10 min after the last dimethylxanthine injection) (20) , and no protective effects on in vivo acute pancreatitis were seen. Since pancreatic cellular injury initiates and determines severity in acute pancreatitis, the protective effect of caffeine on acute pancreatitis is likely to have been mediated by inhibition of IP 3 R-mediated Ca 2+ release.
The effects of calcium elevation in mitochondria:
The pancreatic acinar cell typifies non-excitable exocrine cells with a high secretory turnover that is heavily dependent on mitochondrial production of ATP (61) . While zymogen activation has long been considered the principle mechanism of injury (41, 59) , mitochondrial dysfunction has been increasingly implicated (12, 34, 44, 68, 70, 74, 80) (54) and is part of the systemic inflammatory response contributing to multiple organ failure (62) . Further pancreatic injury is driven through tumor necrosis factor receptor activation that also promotes MPTP opening (31) and calcium deregulation, activating calcineurin and calcineurin-dependent transcription factor nuclear factor of activated T cells (51).
Therapeutic avenues for acute pancreatitis:
Our novel human data support the potential applicability of SOCE inhibition as a treatment for clinical acute pancreatitis (Figure 2 ). Both GSK-7975A and CM_128 blocked SOCE promptly, shown to result in complete block of human ORAI1 by CM_128 (84) . While an action on other ORAI channels cannot be excluded and could be desirable, ORAI1 is the primary channel for SOCE into pancreatic acinar cells (24, 45) , blocked by both compounds. ORAI channels also contribute to inflammatory cell responses, including neutrophil migration and activation (3) from intracellular stores could deplete these stores to deleterious levels, inducing or exacerbating ER stress (48) .
Both
ORAI inhibitory compounds were administered after disease induction to model treatment of clinical acute pancreatitis, but delay in administration of either compound to six hours after disease induction resulted in diminished efficacy, dependent on the endpoint measured and the model employed (84) . While biological time courses including that of acute pancreatitis are longer in humans than mice (15, 43, 59, 62) , with pancreatic necrosis typically detected within days rather than hours (73) , human pancreatic acinar necrotic cell death pathway activation may begin in clinical acute pancreatitis at an early stage after disease onset, shown here in mouse models within six hours of onset. Door-to-needle times of less than 60 minutes are established guidelines for patients with acute myocardial infarction (30 min) (57) and acute ischemic stroke (60 min) (37), making every second count, with national and international quality improvement initiatives underway towards fully achieving these (19) .
Although pancreatic necrosis has a less rapid time course and is characteristically not the result of major arterial occlusion (59), the translational implication of our work is that door-to-needle time is an important issue in administration of any treatment for acute pancreatitis that targets the pathogenesis of pancreatic injury, which drives the disease. Previously clinical trials of treatments for acute pancreatitis have 'enriched' recruitment with patients predicted to have severe disease (often with recruitment up to 72 h after admission) (77) , which delays initiation of therapy. Furthermore, the expansion of disease categories from the original Atlanta Classification (mild and severe) (6) into the revised Atlanta (mild, moderate and severe) (2) and DeterminantsBased (mild, moderate, severe, critical) (14) classification, further complicates patient selection from among these potentially overlapping subgroups. To minimize door-to-needle time a quicker and more accurate approach to the selection of patients is required for trials of any therapy, such as that offered here with ORAI inhibition by CM_128, a novel molecular entity currently undergoing preclinical toxicological evaluation prior to phase I trials. 8 With respect to inhibition of Ca 2+ release within the pancreatic acinar cell rather than Ca 2+ entry into the cell, it is important to note that in our studies high doses of caffeine were required to reduce the severity of experimental acute pancreatitis.
The most effective 25 mg/kg regimen extended into toxicity, indicative of a very narrow therapeutic index. At this dose the number of hourly injections had to be reduced from seven to two in FAEE-AP to avoid mortality; in CER-AP, 50 mg/kg resulted in caffeine intoxication syndrome, although at 25 mg/kg no visible side effects were observed. In humans even 10 mg/kg caffeine would be likely to induce caffeine intoxication, with florid neuro-excitotoxic and other undesirable side effects (20) . There is marked individual variability in caffeine metabolism and pharmacokinetics (20) ; since the half-life in humans typically ranges from three to seven hours, repeated high doses would be hazardous, unless rapid therapeutic monitoring were to be possible.
Nevertheless our study has demonstrated proof of principle that caffeine causes marked amelioration of experimental acute pancreatitis, largely through inhibition of IP 3 R-mediated signalling. Medicinal chemistry starting with the template of caffeine and/or other compounds that inhibit IP 3 R-mediated signalling could lead to more potent, selective and safer drug candidates for acute pancreatitis. This approach, however, might have effects on IP 3 Rmediated signalling in other cells, tissues and organs including the brain and other solid organs. The effect of this approach was remarkably effective in both isolated human and murine pancreatic acinar cells as well as in four models of experimental acute pancreatitis (52) . The attractions of this approach are made stronger by the relative modest phenotype of the cyclophilin D knockout that is able to grow, develop and breed normally; there is an extensive range of pathologies that cyclophilin D knockout protects against, although capacity for exercise is reduced and there is some impact on memory in later life (17, 18) . These effects are unlikely to be important in short-term administration as would be required in acute pancreatitis, and has not proven a problem in long-term administration of cyclosporin A.
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